Precision medicine and developmental therapeutics in gynaecologic oncology
Therapeutic relevance of gene expression signatures in ovarian cancer: Examining the evidence
Date
18 Dec 2015Session
Precision medicine and developmental therapeutics in gynaecologic oncologyPresenters
Ruby HuangAuthors
R. HuangAuthor affiliations
- Cancer Science Institute Of Singapore, National university of Singapore, 117599 - Singapore/SG
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
New insights into resistance of treatment
Presenter: David Bowtell
Session: Precision medicine and developmental therapeutics in gynaecologic oncology
Resources:
Slides
Webcast
Immunotherapy for gynaecological cancers: Challenges and opportunities
Presenter: Junzo Hamanishi
Session: Precision medicine and developmental therapeutics in gynaecologic oncology
Resources:
Slides
Webcast
Targeted therapies for gynaecological cancers
Presenter: Michael Friedlander
Session: Precision medicine and developmental therapeutics in gynaecologic oncology
Resources:
Slides
Webcast